Portfolio Management Reports
Pharmaceutical Portfolio Management (PH162)
Master portfolio management and drive coordinated execution using benchmarks and best practices from pre-clinical to end of life.
Business Development and Licensing (PH154)
Reinforce business development and licensing capabilities to capitalize on deal opportunities, drive successful negotiations and foster lucrative pharmaceutical and biotechnology partnerships.
Pharmaceutical Lifecycle Management (PH141)
Countering Generic and Biosimilar Threats (PH136)
Protect brand revenues with a multifaceted biosimilar & pharmaceutical generics plan that combines tried-and-true tactics implemented by teams across the industry.
Pharmaceutical Mergers and Acquisitions (PH133)
Realize deal value, target the right pharma acquisition opportunities and complete post-M&A integration as quickly as possible.
Pharmaceutical Alliance Management (PH119)
Craft a robust alliance management strategy to bridge organizational gaps and drive pharma partnership project success while preparing for contingencies.







